Navigation Links
In Vitro Osteogenesis Assay Kit from CHEMICON

ProductsIn Vitro Osteogenesis Assay Kit from CHEMICON
Company CHEMICON
Item In Vitro Osteogenesis Assay Kit
Price $350.00
Description CHEMICON's In Vitro Osteogenesis Assay Kit contains all reagents necessary to efficiently differentiate MC3T3-E1cells to a mature osteoblastic lineage, as determined by staining for mineralization. In addition this kit provides all the necessary reagents and a protocol for quantifying osteogenesis using a standard plate reader. This product is useful for studying the effects of growth factors, drugs and toxic agents on bone formation and for screening candidate osteogenic pharmaceuticals. Also, studies examining the intracellular signaling pathways regulating osteoblast differentiation can be facilitated by use of this kit.

  • Components: Ascorbic Acid 2-Phosphate Solu Glycerol 2- Phosphate Solution Melatonin Solution: Part No. 2 Alizarin Red S Stain Solution 10% Acetic Acid: Part No. 2004 10% Ammonium Hydroxide: Part N 10X ARS Dilution Buffer: Part
Info CHEMICONCHEMICON
CHEMICON International, Inc.
28820 Single Oak Drive
Temecula, CA 92590
Customer Service: 800-437-7500
Tech Support: 800-437-7500
Fax Number: 800-437-7502
Web Site: http://www.chemicon.com
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. In Vitro Toxicity Testing Protocols, Vol 43 from Promega
2. Glutathione-S-Transferase (GST) Colorimetric Assay Kit from Sigma-Aldrich
3. Mast Cell Degranulation colorimetric Assay Kit from CHEMICON
4. PR Competitor Assay Green from Invitrogen
5. PolarScreen Androgen Receptor Competitor Assay Kit, Red from Molecular Probes (Invitrogen)
6. Hydrogen Peroxide / Peroxidase Fluorometric (resorufin) Assay Kit, Fluoro H2O2 from BACHEM
7. PPARGamma-Competitor Assay Kit Green from Invitrogen
8. Total antioxidant capacity Colorimetric Assay Kit from Neogen Corporation
9. PolarScreen Progesterone Receptor Competitor Assay Kit, Far Red from Molecular Probes (Invitrogen)
10. Total Antioxidant Power Colorimetric Assay Kit from Neogen Corporation
11. NDPase (GDPase, UDPase, ADPase) Assay Kit from Sigma-Aldrich
(Date:1/4/2017)... LAS VEGAS , Jan. 4, 2017  For the thousands of ... , a global leader in connected health and biometric measurement devices and ... pressure monitors. On display in A&D Medical,s special CES ... monitors represent the ongoing expansion of the company,s WellnessConnected product ... ...
(Date:12/20/2016)... 2016 The rising popularity of mobility ... is stoking significant interest in keyless access systems. ... low energy (BLE), biometrics and near-field communication (NFC) ... of wireless technologies in the automotive industry. This ... access systems opens the market to specialist companies ...
(Date:12/16/2016)... NEW YORK , Dec. 16, 2016 The global ... reach USD 12.14 billion by 2021 from USD 5.31 billion in ... ... market is mainly driven by technological advancements in medical devices, launch ... devices, rising preference for wireless connectivity among healthcare providers, and increasing ...
Breaking Biology News(10 mins):
(Date:1/13/2017)... ... 13, 2017 , ... FireflySci has been busy rolling out ... diverse customer base. The latest entry in this field is a series of ... Bio-Rad. FireflySci is introducing three distinct varieties including a 10x1mm, 10x2 and 10x4 ...
(Date:1/12/2017)... , ... January 12, 2017 ... ... devices with short response times capable of performing routine electrochemical biosensing has ... screen-printed electrodes provide fast, sensitive detection and quantification of various analytes in ...
(Date:1/12/2017)... Jan. 12, 2017   Protein Sciences Corporation ... of Flublok Influenza Vaccine ®, announced today ... had good safety results and induced strong neutralizing ... The product is expected to advance into human ... addition, the Institute of Technology in Immunobiologicals of ...
(Date:1/11/2017)... ... January 11, 2017 , ... Phase 1 clinical trial data ... the investigational anti-cancer agent tucatinib (formerly ONT-380) against HER2+ breast cancer. The 50 ... of these heavily pretreated patients saw clinical benefit from the drug, with at ...
Breaking Biology Technology: